Current status of nerve agent intoxication pretreatment with pyridostigmine and other pharmacological alternatives;Estado actual del pretratamiento de las intoxicaciones por agentes neurotóxicos de guerra con piridostigmina y otras alternativas farmacológicas

Revista de Toxicologia

Volumn 20, Issue 1, 2003, Pages 1-7

  Pita, René ^a,b   Anadon A ^a   Martinez Larranaga M R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Escuela Militar de Defensa NBQ   (Spain)

Author keywords

DEET; Huperzine A.; Nerve agents; Permethrin; Pretreatment; Pyridostigmine

Indexed keywords

DIETHYLTOLUAMIDE; HUPERZINE A; INSECT REPELLENT; NERVE AGENT; PERMETHRIN; PYRIDOSTIGMINE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG SAFETY; EXPOSURE; HUMAN; INTOXICATION; PERSIAN GULF SYNDROME; REVIEW;

INSECTA;

EID: 0037284583     PISSN: 02127113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Marrs TC (1993) Organophosphate poisoning. Pharmac Ther 58: 51-66.
2. Grob D, Harvey AM (1953) The effects and treatment of nerve gas poisoning. Am J Med 14: 52-63.
3. United States Army Medical Research Institute of Chemical Defense (1998) Special publication: pyridostigmine. USAM-RICD Special Publication 98-01.
4. Tonkopii V (2001) Structure and efficiency of carbamates as drugs for prophylaxis. En: Proceedings of the seventh international symposium on protection against chemical and biological warfare agents. National Defence Research Institute, Umea (Suecia). En prensa.
5. Gall D (1981) The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundam Appl Toxicol 1: 214-216.
6. Dawson RM (1994) Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14: 317-331.
7. a ed., Oxford University Press, New York. 1073-1093.
8. United States Army Medical Research Institute of Chemical Defense (1990) Clinical notes on chemical casualty care: pyridostigmine. USAMRICD Technical Memorandum 90-4.
9. Koplovitz I, Stewart JR (1994) A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol Lett 70: 269-279.
10. Briggs CJ, Simons KJ (1986) Treatment of organophosphorus poisoning: pharmaceutical aspects of antidotes. En: Heyndrickx B (editor) Proceedings of the second world congress on new compounds in biological and chemical warfare. University Press, Gante (Bélgica). 514-523.
11. Dunn MA, Sidell FR (1989) Progress in medical defense against nerve agents. JAMA 262: 649-652.
12. Lennox WJ, Harris LW, Talbot BG, Anderson DR (1985) Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci 37: 793-798.
13. Marino MT, Schuster BG, Brueckner RP, Lin E, Kaminskis A, Lasseter KC (1998) Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J Clin Pharmacol 38: 227-235.
14. a ed., Mc Graw Hill, New York. 161-176.
15. Keeler JR, Hurst CG, Dunn MA (1991) Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 266: 693-695.
16. Gouge SF, Daniels DJ, Smith CE (1994) Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Mil Med 159: 108-111.
17. Institute of Medicine: Committee on health effects associated with exposures during the Gulf War (2000) Illnesses in Gulf War veterans. En: Fulco CE, Liverman CT, Sax HC (editores) Gulf War and health (volume 1): depleted uranium, pyridostigmine, sarin, vaccines. National Academy Press, Washington, D.C. 39-67.
18. Moss JI (2001) Many Gulf War illnesses may be autoimmune disorders caused by the chemical and biological stressors, pyridostigmine bromide, and adrenaline. Med Hypotheses 56: 155- 157.
19. Niesen CE, Shah NS (2000) Pyridostigmine-induced microcephaly. Neurology 54: 1873-1874.
20. Bowman PD, Schuschereba ST, Johnson TW, Woo FJ, McKinney L, Wheeler CR, et al. (1989) Myopathic changes in diaphragm of rats fed pyridostigmine bromide subchronically. Fundam Appl Toxicol 13: 110-117.
21. Kaiser KS, Hawksworth AW, Gray GC (2000) Pyridostigmine bromide intake during the Persian Gulf War is not associated with postwar handgrip strength. Mil Med 165: 165-168.
22. Chaney LA, Rockhold RW, Mozingo JR, Hume AS, Moss JI (1997) Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine. Vet Human Toxicol 39: 214-219.
23. Sharabi Y, Danon YL, Berkenstadt H, Almog S, Mimouni-Bloch A, Zisman A, et al. (1991) Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Isr J Med Sci 27: 656-658.
24. Somani SM, Husain K, Jagannathan R (2001) Pharmacokinetics and pharmacodynamics of carbamates under physical stress. En: Somani SM, Romano JA Jr. (editores) Chemical warfare agents: toxicity at low levels. CRC Press LLC, Florida. 145-189.
25. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I (1996) Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 2: 1382-1385.
26. Fishman RA (1997) Less stress-more pressure? Nat Med 3: 366.
27. Lallement G, Foquin A, Baubichon D, Burckhart MF, Carpentier P, Canini F (1998) Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs. Neurotoxicology 19: 759-766.
28. Grauer E, Alkalai D, Kapon J, Cohen G, Raveh L (2000) Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol 164: 301-304.
29. Sinton CM, Fitch TE, Petty F, Haley RW (2000) Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat. Toxicol Appl Pharmacol 165: 99-105.
30. Tian H, Song X, Bressler J, Pruett S, Pope CN (2002) Neither forced running nor forced swimming affect acute pyridostigmine toxicity or brain-regional cholinesterase inhibition in rats. Toxicology 176: 39-50.
31. Snodgrass HL (1992) Permethrin transfer from treated cloth to the skin surface: potential for exposure in humans. J Toxicol Environ Health 35: 91-105.
32. Wester RM, Tanojo H, Maibach HI, Wester RC (2000) Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption. Toxicol Appl Pharmacol 168: 149-152.
33. a ed., Oxford University Press, New York. 492-496.
34. Taplin D, Meinking TL (1987) Pyrethrins and pyrethroids for the treatment of scabies and pediculosis. Semin Dermatol 6: 125-135.
35. Anadón A, Martínez-Larrañaga MR, Diaz MJ, Bringas P (1991) Toxicokinetics of permethrin in the rat. Toxicol Appl Pharmacol 119: 1-8.
36. a ed., Oxford University Press, New York. 1028-1044.
37. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL (1996) Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 48: 35-56.
38. Hoy JB, Cornell JA, Karlix JL, Schmidt CJ, Tebbett IR, van Haaren F (2000) Interactions of pyridostigmine bromide, DEET and permethrin alter locomotor behavior of rats. Vet Human Toxicol 42: 65-71.
39. Hoy JB, Cornell JA, Karlix JL, Tebbett IR, van Haaren F (2000) Repeated coadministrations of pyridostigmine bromide, DEET, and permethrin alter locomotor behavior of rats. Vet Human Toxicol 42: 72-76.
40. McCain WC, Lee R, Johnson MS, Whaley JE, Ferguson JW, Beall P, et al. (1997) Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat. J Toxicol Environ Health 50: 113-124.
41. Buchholz BA, Pawley NH, Vogel JS, Mauthe RJ (1997) Pyrethroid decrease in central nervous system from nerve agent pretreatment. J Appl Toxicol 17: 231-234.
42. Chaney LA, Wineman RW, Rockhold RW, Hume AS (2000) Acute effects of an insect repellent, N,N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats. Toxicol Appl Pharmacol 165: 107-114.
43. Abou-Donia MB, Goldstein LB, Jones KH, Abdel-Rahman AA, Damodaran TV, Dechkovskaia AM, et al. (2001) Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol Sci 60: 305-314.
44. Griffiths GD, Hornby RJ, Stevens DJ, Scott LAM, Upshall DG (2001) Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. J Appl Toxicol 21: 59-68.
45. Kassa J, Fusek J (1998) The positive influence of a cholinergic-anticholinergic pretreatment and antidotal treatment on rats poisoned with supralethal doses of soman. Toxicology 128: 1-7.
46. Kassa J, Vachek J, Bajgar J, Fusek J (2001) A combination of pyridostigmine with anticholinergic drugs: effective pharmacological pretreatment of soman-poisoned mice. ASA Newsletter 84: 16-19.
47. Xia DY, Wang LX, Pei SQ (1981) The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivo. Fundam Appl Toxicol 1: 217-221.
48. Deshpande SS, Viana GB, Kauffman FC, Rickett DL, Albuquerque EX (1986) Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Fundam Appl Toxicol 6: 566-577.
49. Kirby AW, Townsend AT (1989) The effect of carbamates on the neural portion of the visual system. En: Proceedings of the third international symposium on protection against chemical warfare agents. National Defence Research Institute, Umea (Suecia). 151-152.
50. Philippens IH, Melchers BP, Oliver B, Bruijnzeel PL (2000) Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav 65: 175-182.
51. Sidell FR (1992) Clinical considerations in nerve agent intoxication. En: Somani SM (editor) Chemical warfare agents. Academic Press Inc., San Diego (California). 155-194.
52. Scott EAM, Hollands RN, Wetherell JR (1994) The current UK medical countermeasures for nerve agent poisoning; physostigmine and hyoscine as an alternative to pyridostigmine. En: Price B (editor) Proceedings of the chemical and biological medical treatment symposium. Applied Science and Analysis, Portland (Maine). 1.14-1.17.
53. Stojiljkovic MP, Maksimovic M, Bokonjic D, Kilibarda V, Tadic V, Boskovic B (1998) Adamantanes versus carbamates as prophylactic agents in soman-poisoned rats. En: Proceedings of the sixth international symposium on protection against chemical and biological warfare agents. National Defence Research Institute, Umea (Suecia). 197-202.
54. Patocka J, Kassa J (1999) Huperzine A: prospective prophylactic antidote against organophosphate warfare agent poisoning. ASA Newsletter 71: 16-19.
55. Tonduli LS, Testylier G, Masqueliez C, Lallement G, Momnaur P (2001) Effects of huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 22: 29-37.
56. Ashani Y, Peggins JO, Doctor BP (1992) Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 184: 719-726.
57. Grunwald J, Raveh L, Doctor BP, Ashani Y (1994) Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 54: 991-997.
58. Lallement G, Foquin A, Dorandeu F, Baubichon D, Aubriot S, Carpentier P (2001) Subchronic administration of various pre-treatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. Drug Chem Toxicol 24: 151-164.
59. Laganiere S, Corey J, Tang XC, Wulfert E, Hanin I (1991) Acute and chronic studies with the anticholinesterase huperzine A: effect on central nervous system cholinergic parameters. Neuropharmacology 30: 763-768.
60. Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, et al. (1995) Efficacy of tablet HUP-A on memory, cognition and behavior in Alzheimer's disease. Acta Pharmacologica Sinica 16: 391-395.
61. Qian BC, Wang M, Zhou ZF, Chen K, Zhou RR, Chen GS (1995) Pharmacokinetics of tablet huperzine A in six volunteers. Acta Pharmacologica Sinica 16: 396-398.